Published in Antimicrob Agents Chemother on April 01, 1995
OXA-18, a class D clavulanic acid-inhibited extended-spectrum beta-lactamase from Pseudomonas aeruginosa. Antimicrob Agents Chemother (1997) 5.06
Diversity, epidemiology, and genetics of class D beta-lactamases. Antimicrob Agents Chemother (2009) 4.33
OXA-24, a novel class D beta-lactamase with carbapenemase activity in an Acinetobacter baumannii clinical strain. Antimicrob Agents Chemother (2000) 4.08
Catalytic properties of class A beta-lactamases: efficiency and diversity. Biochem J (1998) 3.47
OXA-15, an extended-spectrum variant of OXA-2 beta-lactamase, isolated from a Pseudomonas aeruginosa strain. Antimicrob Agents Chemother (1997) 2.28
Oxacillinase-mediated resistance to cefepime and susceptibility to ceftazidime in Pseudomonas aeruginosa. Antimicrob Agents Chemother (2001) 2.10
Molecular characterization of OXA-20, a novel class D beta-lactamase, and its integron from Pseudomonas aeruginosa. Antimicrob Agents Chemother (1998) 1.94
Comparison of beta-lactamases of classes A and D: 1.5-A crystallographic structure of the class D OXA-1 oxacillinase. Protein Sci (2003) 1.67
Biochemical characterization of the naturally occurring oxacillinase OXA-50 of Pseudomonas aeruginosa. Antimicrob Agents Chemother (2004) 1.66
Cloning and nucleotide sequence analysis of a gene encoding an OXA-derived beta-lactamase in Acinetobacter baumannii. Antimicrob Agents Chemother (1997) 1.32
Novel class A beta-lactamase Sed-1 from Citrobacter sedlakii: genetic diversity of beta-lactamases within the Citrobacter genus. Antimicrob Agents Chemother (2001) 1.29
Novel OXA-10-derived extended-spectrum beta-lactamases selected in vivo or in vitro. Antimicrob Agents Chemother (1998) 1.28
Common beta-lactamases inhibit bacterial biofilm formation. Mol Microbiol (2005) 1.16
Whole genome sequence analysis of the first Australian OXA-48-producing outbreak-associated Klebsiella pneumoniae isolates: the resistome and in vivo evolution. PLoS One (2013) 1.04
OXA-46, a new class D beta-lactamase of narrow substrate specificity encoded by a blaVIM-1-containing integron from a Pseudomonas aeruginosa clinical isolate. Antimicrob Agents Chemother (2005) 1.04
Characterization of OXA-29 from Legionella (Fluoribacter) gormanii: molecular class D beta-lactamase with unusual properties. Antimicrob Agents Chemother (2001) 1.02
Antibiotics as selectors and accelerators of diversity in the mechanisms of resistance: from the resistome to genetic plasticity in the β-lactamases world. Front Microbiol (2013) 0.93
Variations within class-A β-lactamase physiochemical properties reflect evolutionary and environmental patterns, but not antibiotic specificity. PLoS Comput Biol (2013) 0.87
The ybxI gene of Bacillus subtilis 168 encodes a class D beta-lactamase of low activity. Antimicrob Agents Chemother (2004) 0.82
Acquired Class D β-Lactamases. Antibiotics (Basel) (2014) 0.77
First Report of OXA-4, an ESBL Isolated from Pseudomonas aeruginosa a South Indian Strain. Indian J Microbiol (2012) 0.75
DNA sequencing with chain-terminating inhibitors. Proc Natl Acad Sci U S A (1977) 790.54
Improved M13 phage cloning vectors and host strains: nucleotide sequences of the M13mp18 and pUC19 vectors. Gene (1985) 213.67
A comprehensive set of sequence analysis programs for the VAX. Nucleic Acids Res (1984) 181.98
A complementation analysis of the restriction and modification of DNA in Escherichia coli. J Mol Biol (1969) 71.21
Production of single-stranded plasmid DNA. Methods Enzymol (1987) 39.38
The structure of beta-lactamases. Philos Trans R Soc Lond B Biol Sci (1980) 17.57
A standard numbering scheme for the class A beta-lactamases. Biochem J (1991) 17.44
Kanamycin-resistant vectors that are analogues of plasmids pUC8, pUC9, pEMBL8 and pEMBL9. Gene (1986) 7.97
The active-site-serine penicillin-recognizing enzymes as members of the Streptomyces R61 DD-peptidase family. Biochem J (1988) 7.51
Precise insertion of antibiotic resistance determinants into Tn21-like transposons: nucleotide sequence of the OXA-1 beta-lactamase gene. Proc Natl Acad Sci U S A (1987) 5.28
Comparison of the sequences of class A beta-lactamases and of the secondary structure elements of penicillin-recognizing proteins. Antimicrob Agents Chemother (1991) 5.05
Phylogeny of LCR-1 and OXA-5 with class A and class D beta-lactamases. Mol Microbiol (1992) 4.34
Sequence of the OXA2 beta-lactamase: comparison with other penicillin-reactive enzymes. FEBS Lett (1985) 3.69
Sequence of PSE-2 beta-lactamase. Antimicrob Agents Chemother (1988) 3.65
Refined crystal structure of beta-lactamase from Citrobacter freundii indicates a mechanism for beta-lactam hydrolysis. Nature (1990) 3.56
Progressive alignment and phylogenetic tree construction of protein sequences. Methods Enzymol (1990) 3.55
On the origin of bacterial resistance to penicillin: comparison of a beta-lactamase and a penicillin target. Science (1986) 2.88
The crystal structure of the beta-lactamase of Streptomyces albus G at 0.3 nm resolution. Biochem J (1987) 2.59
Beta-lactamase of Bacillus licheniformis 749/C at 2 A resolution. Proteins (1990) 2.49
Refined crystal structure of beta-lactamase from Staphylococcus aureus PC1 at 2.0 A resolution. J Mol Biol (1991) 2.44
Nucleotide sequence and phylogeny of SHV-2 beta-lactamase. Antimicrob Agents Chemother (1990) 2.26
Tertiary structural similarity between a class A beta-lactamase and a penicillin-sensitive D-alanyl carboxypeptidase-transpeptidase. Nature (1986) 2.16
Molecular structure and interrelationships of multiresistance beta-lactamase transposons. Plasmid (1988) 2.11
Cloning and expression of a cloxacillin-hydrolyzing enzyme and a cephalosporinase from Aeromonas sobria AER 14M in Escherichia coli: requirement for an E. coli chromosomal mutation for efficient expression of the class D enzyme. Antimicrob Agents Chemother (1994) 2.10
Nucleotide sequence of the PSE-4 carbenicillinase gene and correlations with the Staphylococcus aureus PC1 beta-lactamase crystal structure. J Biol Chem (1990) 1.95
Sequence analysis and evolutionary perspectives of ROB-1 beta-lactamase. Antimicrob Agents Chemother (1990) 1.92
Beta-lactamase of Bacillus licheniformis 749/C. Refinement at 2 A resolution and analysis of hydration. J Mol Biol (1991) 1.79
Sequencing and expression of aadA, bla, and tnpR from the multiresistance transposon Tn1331. Plasmid (1990) 1.75
Site-directed mutagenesis of beta-lactamase I. Single and double mutants of Glu-166 and Lys-73. Biochem J (1990) 1.73
Characterization of the blaCARB-3 gene encoding the carbenicillinase-3 beta-lactamase of Pseudomonas aeruginosa. Gene (1991) 1.62
Oxacillin-hydrolysing beta-lactamases. A comparative analysis at nucleotide and amino acid sequence levels. Eur J Biochem (1989) 1.56
Cloning and expression of the imipenem-hydrolyzing beta-lactamase operon from Pseudomonas maltophilia in Escherichia coli. Antimicrob Agents Chemother (1988) 1.50
A direct comparison of two unusual R-factor-mediated -lactamases. Biochem J (1972) 1.46
Site-saturation mutagenesis and three-dimensional modelling of ROB-1 define a substrate binding role of Ser130 in class A beta-lactamases. Protein Eng (1992) 1.34
Development of natural and synthetic DNA probes for OXA-2 and TEM-1 beta-lactamases. Antimicrob Agents Chemother (1987) 1.32
Mapping of the plasmid (pLQ3) from Achromobacter and cloning of its cephalosporinase gene in Escherichia coli. Gene (1982) 1.09
Nucleotide sequence of an OXA-2 beta-lactamase gene from the R-plasmid R1767 derived plasmid pBP11 and comparison to closely related resistance determinants found in R46 and Tn2603. J Gen Microbiol (1989) 1.00
Phylogenetic tree and sequence similarity of beta-lactamases. Mol Phylogenet Evol (1993) 0.99
Immunological comparison between OXA-2 beta-lactamase and those mediated by other R plasmids. Antimicrob Agents Chemother (1985) 0.98
A standard numbering scheme for the class A beta-lactamases. Biochem J (1991) 17.44
Phylogeny of LCR-1 and OXA-5 with class A and class D beta-lactamases. Mol Microbiol (1992) 4.34
Cloning of SHV-2, OHIO-1, and OXA-6 beta-lactamases and cloning and sequencing of SHV-1 beta-lactamase. Antimicrob Agents Chemother (1990) 3.26
Molecular cloning and DNA homology of plasmid-mediated beta-lactamase genes. Mol Gen Genet (1987) 3.12
Decreased outer membrane permeability in imipenem-resistant mutants of Pseudomonas aeruginosa. Antimicrob Agents Chemother (1989) 2.52
Role of Ser-238 and Lys-240 in the hydrolysis of third-generation cephalosporins by SHV-type beta-lactamases probed by site-directed mutagenesis and three-dimensional modeling. J Biol Chem (1993) 2.37
Nucleotide sequence and phylogeny of SHV-2 beta-lactamase. Antimicrob Agents Chemother (1990) 2.26
Multiplex polymerase chain reaction for detection and differentiation of the microbial insecticide Bacillus thuringiensis. Appl Environ Microbiol (1993) 1.96
Nucleotide sequence of the PSE-4 carbenicillinase gene and correlations with the Staphylococcus aureus PC1 beta-lactamase crystal structure. J Biol Chem (1990) 1.95
Sequence analysis and evolutionary perspectives of ROB-1 beta-lactamase. Antimicrob Agents Chemother (1990) 1.92
Comparative analysis of the 16S to 23S ribosomal intergenic spacer sequences of Bacillus thuringiensis strains and subspecies and of closely related species. Appl Environ Microbiol (1995) 1.82
Identification of group B streptococcal Sip protein, which elicits cross-protective immunity. Infect Immun (2000) 1.73
Characterization of the blaCARB-3 gene encoding the carbenicillinase-3 beta-lactamase of Pseudomonas aeruginosa. Gene (1991) 1.62
Structural and functional characterization of tnpI, a recombinase locus in Tn21 and related beta-lactamase transposons. J Bacteriol (1990) 1.60
Molecular heterogeneity of the L-1 metallo-beta-lactamase family from Stenotrophomonas maltophilia. Antimicrob Agents Chemother (1998) 1.57
Cloning and expression of the imipenem-hydrolyzing beta-lactamase operon from Pseudomonas maltophilia in Escherichia coli. Antimicrob Agents Chemother (1988) 1.50
Site-saturation mutagenesis and three-dimensional modelling of ROB-1 define a substrate binding role of Ser130 in class A beta-lactamases. Protein Eng (1992) 1.34
Development of natural and synthetic DNA probes for OXA-2 and TEM-1 beta-lactamases. Antimicrob Agents Chemother (1987) 1.32
The impact of UGT1A8, UGT1A9, and UGT2B7 genetic polymorphisms on the pharmacokinetic profile of mycophenolic acid after a single oral dose in healthy volunteers. Clin Pharmacol Ther (2007) 1.28
Inducible overexpression of a toxic protein by an adenovirus vector with a tetracycline-regulatable expression cassette. J Virol (1998) 1.25
Strategies for isolation of in vivo expressed genes from bacteria. FEMS Microbiol Rev (1999) 1.16
Molecular characterization of the class II multiresistance transposable element Tn1403 from Pseudomonas aeruginosa. Antimicrob Agents Chemother (1991) 1.14
Insights into the molecular basis for the carbenicillinase activity of PSE-4 beta-lactamase from crystallographic and kinetic studies. Biochemistry (2001) 1.08
Candidate Neisseria meningitidis NspA vaccine. J Biotechnol (2000) 1.03
High-dose etoposide and melphalan, and autologous bone marrow transplantation for patients with advanced Hodgkin's disease: importance of disease status at transplant. J Clin Oncol (1993) 1.03
Molecular basis of antibiotic resistance and beta-lactamase inhibition by mechanism-based inactivators: perspectives and future directions. FEMS Microbiol Rev (2000) 1.01
Evolutionary perspectives on multiresistance beta-lactamase transposons. J Bacteriol (1989) 1.01
Defined oligonucleotide tag pools and PCR screening in signature-tagged mutagenesis of essential genes from bacteria. Biotechniques (1999) 1.01
New adenovirus vectors for protein production and gene transfer. Cytotechnology (1998) 1.01
Animal models of chronic lung infection with Pseudomonas aeruginosa: useful tools for cystic fibrosis studies. Lab Anim (2008) 1.01
Construction of a DNA probe and detection of Actinobacillus pleuropneumoniae by using polymerase chain reaction. J Clin Microbiol (1991) 1.01
Detection of the pathogenic parasite Toxoplasma gondii by specific amplification of ribosomal sequences using comultiplex polymerase chain reaction. J Clin Microbiol (1993) 1.00
Genomics of the 35-kb pvd locus and analysis of novel pvdIJK genes implicated in pyoverdine biosynthesis in Pseudomonas aeruginosa. FEMS Microbiol Lett (2000) 0.99
In vitro reconstruction of the biosynthetic pathway of peptidoglycan cytoplasmic precursor in Pseudomonas aeruginosa. FEMS Microbiol Lett (2001) 0.99
Physical and genetic mapping of cloned ribosomal DNA from Toxoplasma gondii: primary and secondary structure of the 5S gene. Gene (1992) 0.98
Identification of a ROB-1 beta-lactamase in Haemophilus ducreyi. Antimicrob Agents Chemother (1992) 0.98
Intranasal immunization with gonococcal outer membrane preparations reduces the duration of vaginal colonization of mice by Neisseria gonorrhoeae. J Infect Dis (2000) 0.93
Structure of CARB-4 and AER-1 carbenicillin-hydrolyzing beta-lactamases. Antimicrob Agents Chemother (1998) 0.93
Roles of amino acids 161 to 179 in the PSE-4 omega loop in substrate specificity and in resistance to ceftazidime. Antimicrob Agents Chemother (1998) 0.92
In vivo-induced genes in Pseudomonas aeruginosa. Infect Immun (2000) 0.92
Physical mapping of 32 genetic markers on the Pseudomonas aeruginosa PAO1 chromosome. Microbiology (1996) 0.90
Vasculitic neuropathy in rheumatoid disease and Sjögren syndrome. Neurology (1982) 0.89
Pseudomonas aeruginosa PAO1 bacterial artificial chromosomes: strategies for mapping, screening, and sequencing 100 kb loci of the 5.9 Mb genome. Microb Comp Genomics (1998) 0.88
Molecular distribution of ROB-1 beta-lactamase in Actinobacillus pleuropneumoniae. Antimicrob Agents Chemother (1991) 0.88
Molecular cloning and expression of the imipenem-hydrolyzing beta-lactamase gene from Pseudomonas maltophilia in Escherichia coli. Rev Infect Dis (1988) 0.88
Epoetin alfa therapy increases hemoglobin levels and improves quality of life in patients with cancer-related anemia who are not receiving chemotherapy and patients with anemia who are receiving chemotherapy. J Clin Oncol (2001) 0.88
Peripheral neuropathy following high-dose etoposide and autologous bone marrow transplantation. Bone Marrow Transplant (1994) 0.86
ASD-GFP vectors for in vivo expression technology in Pseudomonas aeruginosa and other gram-negative bacteria. Biotechniques (1998) 0.86
Mini-BEAM as salvage therapy for relapsed or refractory Hodgkin's disease before intensive therapy and autologous bone marrow transplantation. J Clin Oncol (1995) 0.86
Microsatellite instability in childhood T cell acute lymphoblastic leukemia. Leukemia (1997) 0.85
Structure-function studies of Ser-289 in the class C beta-lactamase from Enterobacter cloacae P99. Antimicrob Agents Chemother (1999) 0.84
Effect of antimicrobial prophylaxis on hematopoietic recovery following autologous bone marrow transplantation: ciprofloxacin versus co-trimoxazole. Bone Marrow Transplant (1995) 0.84
Structure-function analysis of alpha-helix H4 using PSE-4 as a model enzyme representative of class A beta-lactamases. Protein Eng (2000) 0.84
Monoclonal antibodies to TEM-1 plasmid-mediated beta-lactamase. Antimicrob Agents Chemother (1987) 0.83
Detection of genes essential in specific niches by signature-tagged mutagenesis. Curr Opin Biotechnol (2000) 0.81
Characterization of a PSE-4 mutant with different properties in relation to penicillanic acid sulfones: importance of residues 216 to 218 in class A beta-lactamases. Antimicrob Agents Chemother (1998) 0.81
Discovering essential and infection-related genes. Curr Opin Microbiol (2001) 0.80
Cloning, over-expression and purification of Pseudomonas aeruginosa murC encoding uridine diphosphate N-acetylmuramate: L-alanine ligase. FEMS Microbiol Lett (2000) 0.79
Molecular cloning, complete sequence of the small subunit ribosomal RNA coding region and phylogeny of Toxoplasma gondii. Mol Biochem Parasitol (1993) 0.78
The influence of erythropoietin on cognitive function in women following chemotherapy for breast cancer. Psychooncology (2009) 0.78
Fatty acid profiles of serum phospholipids in patients suffering rheumatoid arthritis. Prog Lipid Res (1981) 0.78
Secondary structures and features of the 18S, 5.8S and 26S ribosomal RNAs from the Apicomplexan parasite Toxoplasma gondii. Gene (1996) 0.77
Epoetin alfa in cancer patients: evidence-based guidelines. J Pain Symptom Manage (2001) 0.76
Comparative Analysis of the 16S to 23S Ribosomal Intergenic Spacer Sequences of Bacillus thuringiensis Strains and Subspecies and of Closely Related Species. Appl Environ Microbiol (1995) 0.76
Outcomes of reduced-intensity conditioning allo-SCT for Hodgkin's lymphoma: a national review by the Canadian Blood and Marrow Transplant Group. Bone Marrow Transplant (2009) 0.75
[46 episodes of cardiac resuscitation]. Laval Med (1968) 0.75
Evaluation of inhibition of the carbenicillin-hydrolyzing beta-lactamase PSE-4 by the clinically used mechanism-based inhibitors. FEBS Lett (2000) 0.75
Operationally defined single- and double-stranded DNA antigens in the Farr assay: diagnostic value. Eur J Clin Invest (1979) 0.75
Development of gene probes and evolutionary relationships of the PSE-4 bla gene to plasmid-mediated beta-lactamases of gram-negative bacteria. Mol Cell Probes (1989) 0.75
Interleukin-3 followed by GM-CSF for delayed engraftment after autologous bone marrow transplantation. Exp Hematol (1993) 0.75
Systematic site-saturation mutagenesis of ROB-1 beta-lactamase: efficiency of T4 polymerase and oligonucleotide synthesis. Biotechniques (1991) 0.75
Combined results of two phase II studies of Taxol (paclitaxel) in patients with relapsed or refractory lymphomas. Leuk Lymphoma (1999) 0.75
Toxoplasma gondii: structure and characterization of the 26S ribosomal RNA and peptidyl transferase domain. Exp Parasitol (1996) 0.75
Two different schedules for integrating filgrastim as adjuvant therapy in the treatment of patients with advanced stage Hodgkin's lymphoma receiving MOPP/ABV hybrid chemotherapy. Cancer Chemother Pharmacol (1999) 0.75
Combinatorial biochemistry and shuffling of TEM, SHV and Streptomyces albus omega loops in PSE-4 class A beta-lactamase. J Antimicrob Chemother (2000) 0.75
[The stiff-man syndrome: postural discharge of motor units]. Union Med Can (1984) 0.75